Genmab A/S Annual Shareholders Meeting Transcript
/-
(audio in progress) to Genmab's 2026 Annual (audio in progress) see so many of you in person and welcome also to those of you joining us via webcast.
I'm Deirdre Connelly, Chair of Genmab's Board of Directors. I would like to begin by introducing the other members of our Board. Deputy Chair, Pernille Erenbjerg, as well as Anders Gersel Pedersen, Rolf Hoffmann, Elizabeth O'Farrell, and Paolo Paoletti.
We also have three employee Board members. These are Martin Schultz, Michael Kavanagh, and Mijke Zachariasse.
Next, our company's executive managers. Here on stage are Jan van De Winkel, Genmab's Chief Executive Officer; and Anthony Pagano, Chief Financial Officer.
In the audience today, we have Judith Klimovsky, Chief Development Officer; Brad Bailey, Chief Commercial Officer; Tahi Ahmadi, Chief Medical Officer; Greg Mueller, Chief Legal Officer; Chris Cozic, Chief People Officer; Martine van Vugt, Chief Strategy Officer; and Rayne Waller, Chief Technical Operations Officer.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
